Avid Uptake of Gallium-67 in Multiple Myeloma: An Additional Indicator of the Aggressive Phase

Ga-67 scans were performed at three-month intervals in a 52-year-old man with an extensively aggressive variant of multiple myeloma, characterized by anaplastic tumor cells, less increase in serum levels of monoclonal IgA than might be expected from an extensive growth of extraosseous lesions, fever...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 1987-06, Vol.12 (6), p.482-484
Main Authors: KANOH, TADASHI, OHNO, TATSUHARU, UCHINO, HARUTO, YAMAMOTO, ITSUO, TORIZUKA, KANJI
Format: Article
Language:English
Subjects:
Biological and medical sciences
Bone and Bones - diagnostic imaging
Gallium Radioisotopes
Humans
Immunodeficiencies. Immunoglobulinopathies
Immunoglobulinopathies
Immunopathology
Male
Medical sciences
Middle Aged
Multiple Myeloma - diagnostic imaging
Multiple Myeloma - pathology
Radionuclide Imaging
Skull - diagnostic imaging
Technetium Tc 99m Medronate
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ga-67 scans were performed at three-month intervals in a 52-year-old man with an extensively aggressive variant of multiple myeloma, characterized by anaplastic tumor cells, less increase in serum levels of monoclonal IgA than might be expected from an extensive growth of extraosseous lesions, fever without evidence of infection, and short survival time. The findings on the Ga-67 study showed a rapid extension of extraosseous lesions during this aggressive phase. Aggressive multiple myeloma should be included in the list of clinical applications of Ga-67 citrate to tumor imaging.
ISSN:0363-9762
1536-0229
DOI:10.1097/00003072-198706000-00020